How do I buy HIMS & HERS HEALTH INC (HIMS) stock?

Buying HIMS & HERS HEALTH INC (HIMS) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and complete KYC. Make a deposit. Search for the code "HIMS", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy HIMS by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if HIMS is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

HIMS & HERS HEALTH INC (HIMS) Stock

Q: What is the minimum investment for HIMS on Gotrade?

On Gotrade , you don't have to buy a full lot. With fractional shares, you can start investing in HIMS & HERS HEALTH INC from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NYSE · HIMS

Trade HIMS

Key stats

Market cap: $6.57B
Price / Earnings ratio: -46.1x
EPS (TTM): -$2.24
Volume: Loading
52-week high: $52.41
52-week low: $13.74
EPS vs analyst estimate: -10.0%Q3 FY25 · $0.09 vs $0.10
Next earnings report: 2 Nov 2026

Source: third-party data provider, as of October 21, 2026

EPS estimate: analyst consensus

Compare with HIMS

Technical indicators

RSI 14: 50.39
MACD 12/26/9: -0.10
EMA 9 of MACD: -0.03
MACD histogram: -0.07
SMA 50: $29.20; Price above SMA 50
EMA 50: $29.31; Price below EMA 50
SMA 200: $27.22; Price above SMA 200
EMA 200: $29.52; Price below EMA 200

Calculated by Gotrade from daily closing prices, as of October 20, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Hold

Based on 9 analyst ratings

Strong Sell0

Sell0

Hold7

Buy2

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

Revenue

Net income

Net margin %

2024

2025

3B2B930M0

Debt & Balance Sheet

Total assets

Total liabilities

2024

2025

3B2B853M0

Revenue to Profit

2025

$2.3B

Revenue

$0.0

Cost of revenue

$1.7B

Gross profit

$0.0

Operating expenses

$128.4M

Net income

Earnings

EPS forecast

Actual EPS

$0.09

$0.10

Q3FY25

$0.05

Q4FY25

$0.15

Q1FY26

$0.13

Q2FY26

$0.16

Q3FY26

The market is expecting earnings per share of $0.16 for this quarter. The company has not yet shared when it is announcing earnings.

Source: third-party data provider

About HIMS & HERS HEALTH INC

Hims & Hers Health, Inc. is an American telehealth company founded in 2017 and headquartered in San Francisco, California. The company operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling access to medical care for various conditions related to sexual health, hair care, mental health, skincare, primary care, and more. Hims & Hers Health went public in January 2021 through a merger with a special purpose acquisition company (SPAC), Oaktree Acquisition Corp., achieving a valuation of $1.6 billion. HIMS is under NYSE and has a market capitalization of approximately $6.17 billion. In recent developments, the company announced plans to sell Eli Lilly's weight-loss drug, Zepbound, on its telehealth platform as part of an effort to expand its weight-loss offerings. This move aims to provide customers with access to branded versions of weight-loss medications.

SectorConsumer Defensive

IndustryHousehold & Personal Products

Employees2,442

CEOMr. Andrew Dudum

IPO DateSep 13, 2019

HeadquartersSan Francisco, CA

Key Executives

Name	Title	Year Born
Mr. Andrew Dudum	Co-Founder, Chairman & CEO	1988
Mr. Mike Chi	Chief Operating Officer	1980
Mr. Mohamed ElShenawy	Chief Technology Officer	1975
Ms. Soleil Teubner Boughton J.D.	Chief Legal Officer & Corporate Secretary	1978
Dr. Patrick Carroll M.D.	Global Chief Medical Officer	1958
Ms. Deborah M. Autor J.D.	Chief Policy Officer & Director	1967
Dr. Peter Stahl M.D.	Senior Vice President of Men's Reproductive & Sexual Health	—
Dr. Daniel Lieberman M.D.	Senior Vice President of Mental Health	—
Dr. Craig Primack M.D.	Senior Vice President of Weight Loss	—
Mr. Dan Kenger	Chief Design Officer	—

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021										+2.8	-20.2	+6.5
2022	-27.7	+6.7	+5.5	-20.6	-6.7	+12.4	+29.2	+2.1	-10.7	-18.3	+36.9	+0.5
2023	+31.0	+40.9	-14.0	+12.4	-25.6	+5.6	-1.5	-23.4	-8.2	-7.3	+50.9	+0.8
2024	-11.0	+46.4	+17.9	-20.0	+55.2	-1.5	-0.8	-20.4	+27.0	-2.5	+58.3	-21.6
2025	+47.9	+15.8	-27.4	+6.6	+56.4	-12.2	+38.0	-32.3	+36.6	-19.3	-10.4	-13.4
2026	-18.9	-45.1	+26.0	+36.9	-4.6	+24.9	-26.1	-4.0	+4.7	-0.3

Stocks in the same sector

FAQ

Buying HIMS & HERS HEALTH INC (HIMS) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and complete KYC.
Make a deposit.
Search for the code "HIMS", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy HIMS by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full lot. With fractional shares, you can start investing in HIMS & HERS HEALTH INC from just $1. A small budget shouldn't stop you from building a US stock portfolio.

At the moment, HIMS & HERS HEALTH INC (HIMS) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track HIMS's performance via the price chart in the Gotrade app.

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place orders 24/7. Transactions will be executed when the US market (NYSE/NASDAQ) is open, from 9:30 PM to 4:00 AM WIB, or 8:30 PM to 3:00 AM WIB during Daylight Saving Time. Gotrade also provides access to pre-market and after-hours trading, so you have more flexibility and aren't limited to regular working hours.

Market hours may change due to daylight saving time and holidays. In Gotrade, you can see the market status (open/closed) directly in the app.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trading Lebih Cepat. Lebih Mudah. Lebih Cerdas.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

HIMS & HERS HEALTH INC (HIMS) Stock

Key stats

Compare with HIMS

Recent news

Hims Is Reaching the Three Million Member Milestone

Hims Is Reaching the Three Million Member Milestone

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know

HIMS Stock Snaps 3-Day Slump On Peptide Hopes: Trump Administration Reviews Plan That Could Unlock $2.2B Market

HIMS Stock Snaps 3-Day Slump On Peptide Hopes: Trump Administration Reviews Plan That Could Unlock $2.2B Market

Hims & Hers Health, Inc. (HIMS) Suffers a Larger Drop Than the General Market: Key Insights

Hims & Hers Health, Inc. (HIMS) Suffers a Larger Drop Than the General Market: Key Insights

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

Hims Is Reaching the Three Million Member Milestone

Hims Is Reaching the Three Million Member Milestone

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know

HIMS Stock Snaps 3-Day Slump On Peptide Hopes: Trump Administration Reviews Plan That Could Unlock $2.2B Market

HIMS Stock Snaps 3-Day Slump On Peptide Hopes: Trump Administration Reviews Plan That Could Unlock $2.2B Market

Hims & Hers Health, Inc. (HIMS) Suffers a Larger Drop Than the General Market: Key Insights

Hims & Hers Health, Inc. (HIMS) Suffers a Larger Drop Than the General Market: Key Insights

Hims & Hers Expands Australian Women's Health Platform With Hers

Hims & Hers Expands Australian Women's Health Platform With Hers

Hims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026

Hims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026

Hers Launches in Australia, Built to Care for the Whole Woman

Hers Launches in Australia, Built to Care for the Whole Woman

Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It

Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It